Bibliographie (2362)
Cochrane evidence on COVID-19: a round-up
vendredi, 11 septembre 2020 11:09 Écrit par Zouhair SouissiCochrane evidence on COVID-19: a round-up – Evidently Cochrane
The post Cochrane evidence on COVID-19: a round-up appeared first on Links Medicus.
NSAIDs like ibuprofen not tied to severe COVID-19, death
vendredi, 11 septembre 2020 11:09 Écrit par Zouhair SouissiNSAIDs like ibuprofen not tied to severe COVID-19, death – CIDRAP Original Study: Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study – PLOS Medicine Related: The case of ibuprofen: Evidence of huge impact of COVID-19 misinformation when coming from credible sources – Universitat […]
The post NSAIDs like ibuprofen not tied to severe COVID-19, death appeared first on Links Medicus.
![[Abstract Only] Randomized trial on strategies for tracheostomy decannulation](/media/k2/items/cache/b689fad0280b286c898256c8d3b6ee9e_M.jpg)
[Abstract Only] Randomized trial on strategies for tracheostomy decannulation
jeudi, 10 septembre 2020 13:29 Écrit par Zouhair SouissiHigh-Flow Oxygen with Capping or Suctioning for Tracheostomy Decannulation – New England Journal of Medicine Commentary on Twitter New insigths in tracheostomy decannulation. A great pleasure to participate on this study leaded by Gonzalo Hernandez. High-Flow Oxygen with Capping or Suctioning for Tracheostomy Decannulation | NEJM https://t.co/103vhwWlvq @vallhebron @NEJM pic.twitter.com/DzyJSAgn1F — Oriol Roca (@oriolrocag) […]
The post [Abstract Only] Randomized trial on strategies for tracheostomy decannulation appeared first on Links Medicus.
Clinical outcomes in young adults hospitalized with COVID-19
jeudi, 10 septembre 2020 13:29 Écrit par Zouhair SouissiClinical Outcomes in Young US Adults Hospitalized With COVID-19 – JAMA Internal Medicine Editorial: Regardless of Age, Obesity and Hypertension Increase Risks With COVID-19 Commentary: Obesity greatest risk factor for young adults with COVID-19 – MedicalXpress Commentary on Twitter 18 to 34 years old #COVID19 hospitalized outcomes: ✔️21% intensive care, ✔️10% mechanical ventilation✔️2.7% died.✔️Morbid […]
The post Clinical outcomes in young adults hospitalized with COVID-19 appeared first on Links Medicus.
Why COVID-19 is more deadly in people with obesity—even if they’re young
jeudi, 10 septembre 2020 13:29 Écrit par Zouhair SouissiWhy COVID-19 is more deadly in people with obesity—even if they’re young – Science
The post Why COVID-19 is more deadly in people with obesity—even if they’re young appeared first on Links Medicus.
New easy-to-use score for predicting risk of death in patients hospitalized with Covid-19
jeudi, 10 septembre 2020 13:29 Écrit par Zouhair SouissiRisk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score – The BMJ Commentaries: Discovery of four COVID-19 risk groups helps guide treatment – University of Edinburgh AND Expert reaction to a study looking at predicting the risk of death in […]
The post New easy-to-use score for predicting risk of death in patients hospitalized with Covid-19 appeared first on Links Medicus.
![#ERScongress – [Abstract Only] Inhaled Molgramostim therapy in autoimmune pulmonary alveolar proteinosis](/media/k2/items/cache/b3a54ecc0915f9347c3f53fa31d161fe_S.jpg)
#ERScongress – [Abstract Only] Inhaled Molgramostim therapy in autoimmune pulmonary alveolar proteinosis
mercredi, 09 septembre 2020 12:22 Écrit par Zouhair SouissiInhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis – New England Journal of Medicine Commentary on Twitter Original Article: Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis (IMPALA Trial) #ERScongress — NEJM (@NEJM) September 7, 2020
The post #ERScongress – [Abstract Only] Inhaled Molgramostim therapy in autoimmune pulmonary alveolar proteinosis appeared first on Links Medicus.
![#ERScongress – [Abstract Only] Phase 2 trial of the DPP-1 inhibitor Brensocatib in bronchiectasis](/media/k2/items/cache/1ba6f013b03d3119f460bad3db0fbe5d_S.jpg)
#ERScongress – [Abstract Only] Phase 2 trial of the DPP-1 inhibitor Brensocatib in bronchiectasis
mercredi, 09 septembre 2020 12:22 Écrit par Zouhair SouissiPhase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis – New England Journal of Medicine Commentary on Twitter Original Article: Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis (WILLOW Trial) #ERScongress — NEJM (@NEJM) September 7, 2020
The post #ERScongress – [Abstract Only] Phase 2 trial of the DPP-1 inhibitor Brensocatib in bronchiectasis appeared first on Links Medicus.
Opinion: “Facial masking for Covid-19 — potential for “variolation” as we await a vaccine”
mercredi, 09 septembre 2020 12:22 Écrit par Zouhair SouissiFacial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine – New England Journal of Medicine Commentary on Twitter Increasing the proportion of SARS-CoV-2 infections that are asymptomatic with the simple public health measure of universal masking might help make the infection less deadly and increase population-level immunity without severe illnesses […]
The post Opinion: “Facial masking for Covid-19 — potential for “variolation” as we await a vaccine” appeared first on Links Medicus.
Perspective: “When will WE have a vaccine?” — understanding questions and answers about Covid-19 vaccination
mercredi, 09 septembre 2020 12:22 Écrit par Zouhair Souissi“When Will We Have a Vaccine?” — Understanding Questions and Answers about Covid-19 Vaccination – New England Journal of Medicine Commentary on Twitter People inquiring about Covid-19 vaccines often want to know when the public can be confident that available vaccines are safe and effective, when a vaccine will be available to people like them, and […]
The post Perspective: “When will WE have a vaccine?” — understanding questions and answers about Covid-19 vaccination appeared first on Links Medicus.
![[Preprint] Randomized trial: Convalescent plasma not associated with improved outcomes in Covid-19](/media/k2/items/cache/a01253be6ea05e1e8a72b1a2a0636467_XS.jpg)
